Astex Pharmaceuticals Deal History & Licensing Activity
Astex Pharmaceuticals is a large pharma. Over the past three years, Astex Pharmaceuticals has been involved in 2 licensing and acquisition transactions, with a primary focus on Small Molecules (4 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
Small Molecules
Focus Area
Oncology
Astex Pharmaceuticals Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Astex Pharmaceuticals in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Breast cancer therapy research program | Genentech | Small Molecules | Discovery | collaboration | Jul 6, 2026 |
| breast cancer program | Roche | Small Molecules | Discovery | collaboration | Jul 6, 2026 |
Astex Pharmaceuticals Pipeline Focus
Therapeutic areas and modalities where Astex Pharmaceuticals is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Astex Pharmaceuticals's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Oncology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Astex Pharmaceuticals Licensing & Deal Activity
Astex Pharmaceuticals is a large pharma company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Astex Pharmaceuticals ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Astex Pharmaceuticals include Oncology (4 deals and trials). In terms of modality, Astex Pharmaceuticals has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Astex Pharmaceuticals and 700+ other biopharma companies. Use our Solidus to benchmark your asset against Astex Pharmaceuticals's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.